Crossmark

Neue Therapieoptionen beim fortgeschrittenen Prostatakarzinom

Published Online: 2021-04-15

Published Print: 2021-04

Authors

Westhofen, Thilo

Chaloupka, Michael

Herlemann, Annika

Todenhöfer, Tilman

Stief, Christian G.

Kretschmer, Alexander
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

First Online: 15 April 2021

Interessenkonflikte

: Alexander Kretschmer: Beratertätigkeit/Vortragshonorare: Astellas, Bayer, Janssen Cilag, Sanofi.

: Tilman Todenhöfer: Beratertätigkeit/Votragshonorare: Amgen, Astellas, AstraZeneca, Bayer, BMS, Ipsen, Janssen, MSD, Roche, Sanofi.

Document is current